Phase II trial of novel carbidopa/levodopa formulation
November 17, 2009…A new extended-release formulation of carbidopa/levodopa (CD/LD) appears to be as effective as standard CD/LD in stable patients with ParkinsonΒs disease, according to the results of a small phase II study (Hinson et al. Clin Neuropharmacol 2009; 32: 189-192). Subscribe to read more It takes 30 seconds or login using your email address Please enter the email address that you registered the newsletter with Continue…